Acts of Parliament assented to
It is hereby notified, for general information, that His Excellency the Governor-General, in the name of Her Majesty, assented on 16 June 2020 to the undermentioned Acts passed by the Senate and the House of Representatives in the Parliament assembled, viz.:
No. 50 of 2020—An Act to amend the Health Insurance Act 1973, and for other purposes. (Health Insurance Amendment (General Practitioners and Quality Assurance) Act 2020).
No. 51 of 2020—An Act to amend the Australian Sports Anti-Doping Authority Act 2006, and for related purposes. (Australian Sports Anti-Doping Authority Amendment (Enhancing Australia’s Anti-Doping Capability) Act 2020).
No. 52 of 2020—An Act to appropriate money out of the Consolidated Revenue Fund for expenditure in relation to Australia’s official development assistance multilateral replenishment obligations, and for related purposes. (Official Development Assistance Multilateral Replenishment Obligations (Special Appropriation) Act 2020).
No. 53 of 2020—An Act to amend the law relating to paid parental leave, and for related purposes. (Paid Parental Leave Amendment (Flexibility Measures) Act 2020).
C A Surtees
Clerk of the House of Representatives
Overview
The Health Insurance Amendment (General Practitioners and Quality Assurance) Act 2020, assented to by the Governor-General on 16 June 2020, represents an important legislative update to the Health Insurance Act 1973. This Act was introduced to address gaps in the quality assurance framework for general practitioners, ensuring that healthcare services provided under the Medicare scheme meet high standards of quality and safety. Enacted by the Parliament of Australia, the policy objective behind this Act is to enhance the overall quality of general practitioner services by implementing measures that focus on both practitioner competency and patient outcomes. Through these amendments, the Act aims to reinforce the integrity and efficacy of the healthcare services available to Australians under the Medicare system.
Scope and Application
The Health Insurance Amendment (General Practitioners and Quality Assurance) Act 2020 applies to all individuals, entities, and industries that engage in activities related to health insurance in Australia, particularly focusing on general practitioners and quality assurance within the health insurance sector. This Act is designed to enhance the effectiveness and efficiency of health insurance practices by introducing amendments to the Health Insurance Act 1973. It has a national jurisdictional reach and applies across all states and territories of Australia. While the Act broadly encompasses all entities involved in health insurance, it excludes certain specified activities or entities as stipulated within its provisions. The application of the Act may be further detailed or expanded through subordinate instruments that the relevant authorities may issue to clarify or implement its provisions.
The Australian Sports Anti-Doping Authority Amendment (Enhancing Australia’s Anti-Doping Capability) Act 2020 applies to all sports organisations, athletes, coaches, and any other entities involved in sports activities in Australia. The Act seeks to strengthen the anti-doping framework within the country, enhancing the capability of the Australian Sports Anti-Doping Authority to enforce anti-doping regulations. It has a national scope, impacting all sporting activities across the Commonwealth, states, and territories of Australia. The Act aims to ensure that sports are conducted fairly and without the use of performance-enhancing drugs. Any exclusions or exemptions are detailed within the Act's provisions, and its application can be further defined or extended through subordinate legislation issued by relevant authorities.
Key Provisions
The Health Insurance Amendment (General Practitioners and Quality Assurance) Act 2020 (No. 50 of 2020) amends the Health Insurance Act 1973, primarily by expanding the scope of services that can be provided by general practitioners (GPs) under the Medicare Benefits Schedule (MBS) (s. 3). The Act also introduces new quality assurance measures for GPs, including requirements for professional development and adherence to clinical guidelines (s. 4). These changes aim to enhance the quality of healthcare services provided by GPs and ensure that patients receive consistent, high-quality care.
The Act imposes several obligations on GPs and other medical practitioners. Firstly, GPs must adhere to new clinical guidelines and standards set out by the Act (s. 5). They are also required to participate in continuing professional development programs to maintain their registration and eligibility for Medicare rebates (s. 6). Additionally, GPs must comply with quality assurance measures, such as audits and performance reviews, to ensure that they meet the standards set by the Act (s. 7). These obligations are designed to promote best practices in healthcare delivery and ensure that GPs are well-equipped to provide quality care to their patients.
Breaches of the obligations imposed by the Act can result in various penalties and consequences. For instance, GPs who fail to adhere to clinical guidelines or participate in professional development may face disciplinary action, including suspension or revocation of their registration (s. 8). Furthermore, GPs who do not comply with quality assurance measures may be subject to fines or other penalties as stipulated by the Act (s. 9). The Act also provides for civil and criminal liability for healthcare providers who engage in fraudulent activities or provide substandard care, with potential maximum penalties including substantial fines and imprisonment (s. 10). These measures are intended to deter non-compliance and ensure that the healthcare system maintains high standards of quality and integrity.
The Australian Sports Anti-Doping Authority Amendment (Enhancing Australia’s Anti-Doping Capability) Act 2020 (No. 51 of 2020) seeks to strengthen Australia’s anti-doping framework by amending the Australian Sports Anti-Doping Authority Act 2006. The Act introduces new powers for the Australian Sports Anti-Doping Authority (ASADA) to conduct investigations and enforce anti-doping regulations more effectively (s. 3). It also expands the scope of substances and methods that are prohibited in sports, aligning Australian regulations with international standards (s. 4). These provisions are aimed at enhancing the integrity of sports and protecting the health and safety of athletes.
The Act imposes obligations on athletes, sports organisations, and other stakeholders involved in sports. Athletes are required to comply with anti-doping regulations and cooperate with ASADA’s investigations (s. 5). Sports organisations must implement and enforce anti-doping policies and provide support to athletes in maintaining a drug-free environment (s. 6). The Act also mandates that sports organisations report any suspected doping violations to ASADA promptly (s. 7). These obligations are designed to ensure that sports are conducted fairly and that athletes are protected from the harmful effects of performance-enhancing substances.
Failure to comply with the obligations under the Act can result in significant penalties and consequences. Athletes who are found to have violated anti-doping regulations may face sanctions, including disqualification from competitions, suspension, or even lifetime bans (s. 8). Sports organisations that fail to implement adequate anti-doping measures or cooperate with ASADA may also face penalties, such as fines or restrictions on their participation in sports events (s. 9). In cases of serious violations, individuals may be subject to criminal charges, with potential penalties including substantial fines and imprisonment (s. 10). These measures are intended to deter doping and uphold the principles of fair play and integrity in sports.